Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Sell

Price to Earnings Rating

Neutral

Analyst Rating

Buy

Simple Moving Average

Strong Buy

Exponential Moving Average

Strong Buy

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Buy

A

Protagonist Therapeutics, Inc (PTGX)

Pharmaceutical Preparations

https://www.protagonist-inc.com

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

7707 GATEWAY BLVD., SUITE 140
NEWARK, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

08/11/2016

Market Cap

2,433,349,026

Shares Outstanding

57,680,000

Weighted SO

57,678,122

Total Employees

N/A

Upcoming Earnings

11/07/2024

Beta

2.1220

Last Div

0.0000

Range

13.72-42.67

Chg

0.7200

Avg Vol

969358

Mkt Cap

2433349026

Exch

NASDAQ

Country

US

Phone

510 474 0170

DCF Diff

39.5797

DCF

-9.7797

Div Yield

0.0000

P/S

7.6252

EV Multiple

13.4942

P/FV

4.6784

Div Yield %

0.0000

P/E

14.9012

PEG

0.3093

Payout

0.0000

Current Ratio

13.7314

Quick Ratio

13.7314

Cash Ratio

8.5536

DSO

1.5670

DIO

0.0001

Op Cycle

1.5671

DPO

392.9353

CCC

-391.3683

Gross Margin

0.9894

Op Margin

0.4771

Pretax Margin

0.5409

Net Margin

0.5326

Eff Tax Rate

-0.0140

ROA

0.2765

ROE

0.8547

ROCE

0.2657

NI/EBT

0.9846

EBT/EBIT

1.1338

EBIT/Rev

0.4771

Debt Ratio

0.0222

D/E

0.0252

LT Debt/Cap

0.0199

Total Debt/Cap

0.0245

Int Coverage

66.3062

CF/Debt

16.9989

Equity Multi

1.1354

Rec Turnover

232.9343

Pay Turnover

0.9289

Inv Turnover

999999.9999

FA Turnover

26.5226

Asset Turnover

0.5192

OCF/Share

3.7769

FCF/Share

3.7656

Cash/Share

9.1998

OCF/Sales

0.7256

FCF/OCF

0.9970

CF Coverage

16.9989

ST Coverage

87.3743

CapEx Coverage

334.1154

Div&CapEx Cov

334.1154

P/BV

4.6784

P/B

4.6784

P/S

7.6252

P/E

14.9012

P/FCF

10.5409

P/OCF

10.9376

P/CF

10.9376

PEG

0.3093

P/S

7.6252

EV Multiple

13.4942

P/FV

4.6784

DPS

0.0000

Latest Headlines (EST)

Revenue Product Segmentation